Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Efficacy of bacteriophage L522 against bacterial leaf blight of rice in Vietnam

Pham D.T. My, Le T.T. Tien, Le P. Nga, To H. Ngoc, Vo T. Phuc, Hoang A. Hoang.




Abstract

Bacterial leaf blight (BLB) caused by Xanthomonas oryzae pv. oryzae (Xoo) is a destructive rice disease in tropical Asian countries. The conventional approaches to control BLB, such as cultural practices and using chemical pesticides remain ineffective, whereas bacteriophage biocontrol is considered as a promising strategy. The current study investigated the capacity of phage L522 to control BLB in rice. First, phage L522 showed high tolerance over a wide range of temperatures (4, 20, 30, 37, and 50) and pH (4–11) and was also less affected by ultraviolet (UV)-A and UV-B light. Second, the inhibition time of the phage on the growth of Xoo in tryptone soya broth was about 45 h in the in vitro test. More interestingly, in the in vivo trial on rice plants, the efficacy of phage treatment at a concentration of approximately 109 PFU/mL was equivalent to that of a popular commercial pesticide. This study indicated that phage L522 should be a suitable and environmentally-friendly alternative to control BLB, especially applicable to soil and climatic conditions in Vietnam.

Key words: bacteriophage; rice; bacterial leaf blight; biocontrol.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.